Results 171 to 180 of about 55,552 (271)

Attending to Links in the Safety Chain for Drug-Eluting Stents [PDF]

, 2006
Peter J. Fitzgerald, Martin B. Leon
openalex   +1 more source

Drug-eluting stents : Insights into safety and indications

Annals of Saudi Medicine, 2008
Currently, more than 4 million patients receive drug-eluting stents worldwide. Despite recent studies and editorials that have stirred controversy and generated tremendous publicity in the lay press related to the safety of drug-eluting stents for the ...
Hassan Walid
doaj  

Comparative clinical evaluation of safety and efficacy of commonly used drug-eluting stents in coronary artery disease patients after angioplasty in South India: A retro-prospective multi-center study [PDF]

, 2019
Vinoth Prabhu Veeramani, Saranya Selvam, Ahmed M. Hamdan, Vinoth Prabhu Veeramani, M Barton, J Gruntzig, M Husmann, J Rosch, E Benjamin, M Blaha, S Chiuve, M Cushman, S Das, R Deo, S De Ferranti, J Floyd, M Fornage, C Gillespie, C Isasi, M Jimenez, L Jordan, S Judd, D Lackland, J Lichtman, L Lisabeth, S Liu, C Longenecker, R Mackey, K Matsushita, D Mozaffarian, M Mussolino, K Nasir, R Neumar, L Palaniappan, D Pandey, R Thiagarajan, M Reeves, M Ritchey, C Rodriguez, G Roth, W Rosamond, C Sasson, A Towfighi, C Tsao, M Turner, S Virani, J Voeks, J Willey, J Wilkins, J Wu, H Alger, S Wong, P Muntner, J Feinberg, E Nielsen, J Greenhalgh, J Hounsome, N Sethi, S Safi, C Gluud, J Jakobsen, R Gupta, W Kim, S Lee, S Park, Y Kim, S Yun, J Lee, D Park, S Kang, C Lee, J Lee, S Choi, I Seong, B Lee, N Lee, Y Cho, W Shin, S Lee, S Lee, M Hyon, D Bang, W Park, H Kim, J Chae, K Lee, H Park, C Park, S Lee, M Kim, K Park, Y Choi, S Cheong, T Yang, J Jang, S Her, S Park, P Karjalainen, A Ylitalo, J Airaksinen   +99 more
openalex   +1 more source

Biodegradable polymer Biolimus-eluting stent (Nobori®) for the treatment of coronary artery lesions: review of concept and clinical results

Medical Devices: Evidence and Research, 2014
Guillaume Schurtz,1,2 Cédric Delhaye,1 Christopher Hurt,1,2 Henri Thieuleux,1,2 Gilles Lemesle1–3 1Centre Hémodynamique et Unité des Soins Intensifs de Cardiologie, Hôpital Cardiologique, Centre Hospitalier Ré ...
Schurtz G, Delhaye C, Hurt C, Thieuleux H, Lemesle G   +4 more
doaj  

Drug-Eluting Stent Use in Percutaneous Coronary Interventions-A Narrative Review. [PDF]

J Clin Med
Arh R, Balevski I, Granda S, Bevc S.
europepmc   +1 more source

Recurrent cardiac drug-eluting stent thrombosis due to antiphospholipid syndrome: a case report. [PDF]

AME Case Rep
Lin KK, Wine YY, Aye ST.
europepmc   +1 more source

Preclinical Assessment of a Novel Polymer-Free Hybrid Drug Eluting Stent. [PDF]

J Cardiovasc Transl Res
Wild L, Beele A, Seguchi M, Lenz T, Nicol P, Sabic-Halilcevic E, Klosterman GR, Kastrati A, Joner M.   +8 more
europepmc   +1 more source

Drug-Eluting Stenting

JACC: Cardiovascular Interventions, 2008
Romagnoli, Enrico, Sangiorgi, Giuseppe M., Cosgrave, John, Guillet, Edouard, Colombo, Antonio   +4 more
openaire   +1 more source

Patient-tailored Drug-eluting Stent Choice – A Solution for Patients with Diabetes [PDF]

, 2015
Roxana Mehran, Antonio Colombo, Pieter R. Stella, Rafael Romaguera, Gennaro Sardella   +4 more
openalex   +1 more source

Clinical outcomes of drug-coated balloon vs. second-generation drug-eluting stent for coronary in-stent restenosis. [PDF]

Clin Res Cardiol
Krefting J, Krüger N, Friess C, Gräßer C, Schmieder R, Starnecker F, Schwab M, Kufner S, Trenkwalder T, Voll F, Sager HB, Kessler T, Xhepa E, Offenborn F, Dreischulte T, Giacoppo D, Cassese S, Kastrati A, Schunkert H, von Scheidt M, Wiebe J.   +20 more
europepmc   +1 more source